BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buehrle DJ, Wagener MM, Clancy CJ. Outpatient Fluoroquinolone Prescription Fills in the United States, 2014 to 2020: Assessing the Impact of Food and Drug Administration Safety Warnings. Antimicrob Agents Chemother 2021;65:e0015121. [PMID: 33875430 DOI: 10.1128/AAC.00151-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Buehrle DJ, Wagener MM, Nguyen MH, Clancy CJ. Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020. JAMA Netw Open 2021;4:e2126114. [PMID: 34550387 DOI: 10.1001/jamanetworkopen.2021.26114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Taylor LN, Crnich CJ. Accelerating the Growth of Antibiotic Stewardship in Nursing Homes. JAMA Netw Open 2022;5:e220211. [PMID: 35226090 DOI: 10.1001/jamanetworkopen.2022.0211] [Reference Citation Analysis]
3 Mallhi TH, Alanazi AS, Khan YH, Alotaibi NH, Salman M, Alzarea AI, Khan S, Alruwaili NK, Alenazi AS, Alatawi AD, Iqbal Z, Butt MH, Iqbal MS. Assessment of Knowledge Regarding Safety Profile, Use, and Boxed Warnings of Fluoroquinolones Among Healthcare Professionals in Saudi Arabia: A Potential Implication for Drug Regulatory Authorities. Front Med 2022;9:816320. [DOI: 10.3389/fmed.2022.816320] [Reference Citation Analysis]
4 Umarje SP, Alexander CG, Cohen AJ. Ambulatory Fluoroquinolone Use in the United States, 2015-2019. Open Forum Infect Dis 2021;8:ofab538. [PMID: 34901300 DOI: 10.1093/ofid/ofab538] [Reference Citation Analysis]
5 Nishizawa T, Munkjargal M, Ebinuma H, Toyoshima O, Suzuki H. Sitafloxacin for Third-Line Helicobacter pylori Eradication: A Systematic Review. J Clin Med 2021;10:2722. [PMID: 34202993 DOI: 10.3390/jcm10122722] [Reference Citation Analysis]